239 related articles for article (PubMed ID: 7957267)
1. Susceptibility patterns and characterization of beta-lactamases in clinical isolates of Bacteroides fragilis.
Mastrantonio P; Spigaglia P; Sebastianelli A
Eur J Clin Microbiol Infect Dis; 1994 Jun; 13(6):475-80. PubMed ID: 7957267
[TBL] [Abstract][Full Text] [Related]
2. [Can meropenem E-test be used to estimate the presence of carbapenem resistance gene cfiA among Bacteroides fragilis strains?].
Toprak Ülger N; Ilki A; Ozel N; Balkan N; Söyletir G
Mikrobiyol Bul; 2011 Jul; 45(3):385-91. PubMed ID: 21935771
[TBL] [Abstract][Full Text] [Related]
3. Susceptibility patterns and resistance to imipenem in the Bacteroides fragilis group species in Japan: a 4-year study.
Bandoh K; Ueno K; Watanabe K; Kato N
Clin Infect Dis; 1993 Jun; 16 Suppl 4():S382-6. PubMed ID: 8324152
[TBL] [Abstract][Full Text] [Related]
4. [ESBL-positive strains of the Bacteroides fragilis group isolated from patients at the regional hospital center in Płock (Poland)].
Rokosz A; Pawłowska J; Sawicka-Grzelak A; Luczak M
Med Dosw Mikrobiol; 2004; 56(3):245-53. PubMed ID: 15773501
[TBL] [Abstract][Full Text] [Related]
5. beta-Lactamase produced by a highly beta-lactam-resistant strain of Bacteroides fragilis: an obstacle to the chemotherapy of experimental mixed infections.
Ajiki Y; Koga T; Ohya S; Takenouchi T; Yasuda H; Watanabe K; Ueno K
J Antimicrob Chemother; 1991 Oct; 28(4):537-46. PubMed ID: 1761449
[TBL] [Abstract][Full Text] [Related]
6. Survey of antimicrobial susceptibility patterns of the bacteria of the Bacteroides fragilis group isolated from the intestinal tract of children.
Nakano V; Avila-Campos MJ
Mem Inst Oswaldo Cruz; 2004 May; 99(3):319-24. PubMed ID: 15273807
[TBL] [Abstract][Full Text] [Related]
7. [Detection of beta-lactamases in the Bacteroides fragilis group].
Martin C; Dubreuil L; Sedallian A; Romond C
Pathol Biol (Paris); 1990 May; 38(5):470-3. PubMed ID: 2367153
[TBL] [Abstract][Full Text] [Related]
8. Survey of Bacteroides fragilis group susceptibility patterns in Canada.
Bourgault AM; Lamothe F; Hoban DJ; Dalton MT; Kibsey PC; Harding G; Smith JA; Low DE; Gilbert H
Antimicrob Agents Chemother; 1992 Feb; 36(2):343-7. PubMed ID: 1605600
[TBL] [Abstract][Full Text] [Related]
9. First national survey of antibiotic susceptibility of the Bacteroides fragilis group: emerging resistance to carbapenems in Argentina.
Fernández-Canigia L; Litterio M; Legaria MC; Castello L; Predari SC; Di Martino A; Rossetti A; Rollet R; Carloni G; Bianchini H; Cejas D; Radice M; Gutkind G;
Antimicrob Agents Chemother; 2012 Mar; 56(3):1309-14. PubMed ID: 22232282
[TBL] [Abstract][Full Text] [Related]
10. Emergence of carbapenem resistance in Bacteroides fragilis in China.
Gao Q; Wu S; Xu T; Zhao X; Huang H; Hu F
Int J Antimicrob Agents; 2019 Jun; 53(6):859-863. PubMed ID: 30831235
[TBL] [Abstract][Full Text] [Related]
11. Beta-lactamase production, beta-lactam sensitivity and resistance to synergy with clavulanate of 737 Bacteroides fragilis group organisms from thirty-three US centres.
Jacobs MR; Spangler SK; Appelbaum PC
J Antimicrob Chemother; 1990 Sep; 26(3):361-70. PubMed ID: 2228827
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of a new meropenem-EDTA double-ended Etest strip for the detection of the cfiA metallo-beta-lactamase gene in clinical isolates of Bacteroides fragilis.
Bogaerts P; Engelhardt A; Berhin C; Bylund L; Ho P; Yusof A; Glupczynski Y
Clin Microbiol Infect; 2008 Oct; 14(10):973-7. PubMed ID: 18828856
[TBL] [Abstract][Full Text] [Related]
13. New findings in beta-lactam and metronidazole resistant Bacteroides fragilis group.
Fang H; Edlund C; Hedberg M; Nord CE
Int J Antimicrob Agents; 2002 May; 19(5):361-70. PubMed ID: 12007843
[TBL] [Abstract][Full Text] [Related]
14. Characterization of beta-lactamases in clinical isolates of Bacteroides.
Eley A; Greenwood D
J Antimicrob Chemother; 1986 Sep; 18(3):325-33. PubMed ID: 3490466
[TBL] [Abstract][Full Text] [Related]
15. Antibiotic susceptibility of anaerobic bacteria with special reference to Bacteroides fragilis.
Dornbusch K; Nord CE; Olsson-Liljeqvist B
Scand J Infect Dis Suppl; 1979; (19):17-25. PubMed ID: 37593
[TBL] [Abstract][Full Text] [Related]
16. Plasmid-related beta-lactamase production in Bacteroides fragilis strains.
Nakano V; Padilla G; do Valle Marques M; Avila-Campos MJ
Res Microbiol; 2004 Dec; 155(10):843-6. PubMed ID: 15567279
[TBL] [Abstract][Full Text] [Related]
17. Beta-lactamases from Bacteroides fragilis active against oximino-cephalosporins.
Werner RG; Appel KR; Erne AM
Arzneimittelforschung; 1985; 35(1A):348-50. PubMed ID: 3872669
[TBL] [Abstract][Full Text] [Related]
18. Characterization of cephalosporinases from Bacteroides fragilis, Bacteroides thetaiotaomicron and Bacteroides vulgatus.
Sato K; Matsuura Y; Miyata K; Inoue M; Mitsuhashi S
J Antibiot (Tokyo); 1983 Jan; 36(1):76-85. PubMed ID: 6332105
[TBL] [Abstract][Full Text] [Related]
19. Studies on beta-lactamase in Bacteroides fragilis.
Nord CE; Dornbusch K; Olsson B
Infection; 1980; 8 Suppl 2():S167-70. PubMed ID: 6969692
[TBL] [Abstract][Full Text] [Related]
20. Antibacterial activity of new beta-lactam antibiotics on cefoxitin-resistant strains of Bacteroides fragilis.
Dornbusch K; Olsson-Lijequist B; Nord CE
J Antimicrob Chemother; 1980 Mar; 6(2):207-16. PubMed ID: 6966626
[No Abstract] [Full Text] [Related]
[Next] [New Search]
